IL13RA2 has a pro-tumorigenic function in some contexts, notably brain and colorectal cancers [17–21, 57, 58], and to a lesser extent pancreatic [38, 40] and ovarian [39] cancers, but the overall relationship between IL13RA2 expression and patient prognosis remains ambiguous. This evidence concerns the gene IL13RA2 and cancer.